The LP.8.1 is the 2025-2026 updated monovalent formula for Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty) COVID-19 vaccines. It is designed to target the KP.2 variant of the JN.1 lineage. The update aims to restore and improve protection as new variants evolve to partially evade immunity from older vaccine formulas. Health authorities are expected to recommend this updated vaccine for broad use in the upcoming 2025-2026 vaccination season, with specific guidance pending.

Have you ever felt stomachache or tummy pain before an interview? Do you have bowel urgency before an examination? Do you have a faster heartbeat when you are presenting or giving a speech? Why do we react like so?

The average woman depending on her racial ethnicity has a one in 6~9 chance of developing breast cancer during her lifetime, based on a life expectancy of 85 years. Studies have shown that regular screening of women with no symptoms has decreased the number of women who die from breast cancer by approximately 45 percent.